Literature DB >> 32344476

[Temporal-spatial distribution of tuberculosis in China, 2004-2016].

Y S Wang1, J M Wang1, W B Wang1.   

Abstract

Objective: To analyze the spatial distribution pattern and the cluster spots of tuberculosis (TB) patients in China from 2004 to 2016, so as to provide evidence for prevention and control of the disease.
Methods: Using ArcGIS 10.0 software as a platform for data management and presentation, a TB spatial analysis database from 2004 to 2016 was established, and spatial autocorrelation analysis was performed based on the TB epidemics. SaTScan 9.6 software was used for spatiotemporal scanning analysis.
Results: From 2004 to 2016, a total of 13 157 794 cases of pulmonary tuberculosis were registered in China, with the mean annual registered incidence rate as 75.90/100 000 (range: 27.95/100 000-180.82/100 000). Through Global spatial autocorrelation studies, the results showed that the distribution of TB incidence was somehow clustered. The result of local Moran's I autocorrelation analysis showed that Xinjiang, Tibet, Guizhou, Guangxi, Hainan provinces were high-high cluster areas, and Beijing, Hebei, Tianjin, Shandong, Jiangsu, and Shanghai provinces were low-low cluster areas. Result from the Getis-Ord General G spatial autocorrelation analysis showed the existence of fifteen "hot spot" regions, of which three "positive hot spots" were Xinjiang, Tibet, and Hainan provinces, and twelve "negative hot spots" were Beijing, Tianjin, Liaoning, Inner Mongolia, Hebei, Shandong, Jiangsu, Anhui, Shanghai, Shanxi, Henan, Jilin provinces. Using the SaTScan 9.6 software, results from the Phased spatial-temporal analysis identified twelve cluster areas, with statistical significances (P<0.05) among them. Conclusions: From 2004 to 2016, tuberculosis epidemics showed an annual downward trend in China. The average annual rates of notification among provinces were not randomly distributed, showing the existence of obvious spatial aggregation. Numbers of areas with clustering nature that noticed through the temporal and spatial scanning technics had gradually decreased. At the same time, progress had been made in TB control programs, despite the existence of high-risk areas. Development of more strict and targeted prevention and control measures are called for.

Entities:  

Keywords:  Geographic information system; Spatial autocorrelation analysis; Spatial-temporal analysis; Tuberculosis

Mesh:

Year:  2020        PMID: 32344476     DOI: 10.3760/cma.j.cn112338-20190614-00441

Source DB:  PubMed          Journal:  Zhonghua Liu Xing Bing Xue Za Zhi        ISSN: 0254-6450


  5 in total

1.  Unbalanced Risk of Pulmonary Tuberculosis in China at the Subnational Scale: Spatiotemporal Analysis.

Authors:  Maogui Hu; Yuqing Feng; Tao Li; Yanlin Zhao; Jinfeng Wang; Chengdong Xu; Wei Chen
Journal:  JMIR Public Health Surveill       Date:  2022-07-01

2.  Spatial analysis and influencing factors of pulmonary tuberculosis among students in Nanning, during 2012-2018.

Authors:  Dan-Ling Yang; Wen Li; Meng-Hua Pan; Hai-Xia Su; Yan-Ning Li; Meng-Ying Tang; Xiao-Kun Song
Journal:  PLoS One       Date:  2022-05-24       Impact factor: 3.752

3.  Analysis on the characteristics of spatio-temporal evolution and aggregation trend of early COVID-19 in mainland China.

Authors:  Shengxian Bi; Siyu Bie; Xijian Hu; Huiguo Zhang
Journal:  Sci Rep       Date:  2022-03-14       Impact factor: 4.379

4.  Association of sociodemographic and environmental factors with spatial distribution of tuberculosis cases in Gombak, Selangor, Malaysia.

Authors:  Nur Adibah Mohidem; Malina Osman; Zailina Hashim; Farrah Melissa Muharam; Saliza Mohd Elias; Rafiza Shaharudin
Journal:  PLoS One       Date:  2021-06-17       Impact factor: 3.240

5.  The association between extreme temperature and pulmonary tuberculosis in Shandong Province, China, 2005-2016: a mixed method evaluation.

Authors:  Dongzhen Chen; Hua Lu; Shengyang Zhang; Jia Yin; Xuena Liu; Yixin Zhang; Bingqin Dai; Xiaomei Li; Guoyong Ding
Journal:  BMC Infect Dis       Date:  2021-05-01       Impact factor: 3.090

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.